Kitley and colleagues aim to characterize the features of patients with neuromyelitis optica (NMO)/NMO spectrum disorder with myelin-oligodendrocyte glycoprotein (MOG) antibodies and compare them with patients with aquaporin-4 (AQP4) antibody–positive NMO/NMOSD.
Continuing Medical Education
Graphic Jump Location
Richardson and coauthors evaluate the association between serum levels of dichlorodiphenyldichloroethylene and Alzheimer disease (AD) and whether the apolipoprotein genotype modifies the association.
Chan et al examine deep brain stimulation use in Parkinson disease to determine which factors, among a variety of demographic, clinical, and socioeconomic variables, drive deep brain stimulation use in the United States.
Hedström and colleagues investigate the possible influence of alcohol consumption on the risk of developing multiple sclerosis and relate the influence of alcohol to the effect of smoking.
Ascherio and coauthors aim to determine whether serum concentrations of 25-hydroxyvitamin D, a marker of vitamin D status, predict disease activity and prognosis in patients with a first event suggestive of multiple sclerosis (clinically isolated syndrome).
Vardarajan et al determine the incidence rates of dementia and Alzheimer disease in unaffected family members in the National Institute on Aging Genetics Initiative for Late-Onset Alzheimer Disease/National Cell Repository for Alzheimer Disease and Estudio Familiar de Influencia Genetica en Alzheimer family studies.
Mealy and colleagues compare the relapse and treatment failure rates among patients receiving immunosuppression for neuromyelitis optica.
Devenney and coauthors aim to determine the frequency of the C9ORF72 mutation in a frontotemporal dementia (FTD) cohort and to define the clinical, neuropsychological, behavioral, and imaging features of C9ORF72 mutation carriers in comparison with noncarriers in a well-defined behavioral variant–FTD cohort.
Witting and Vissing analyze current information on the effect of pharmacologic treatment of downstream of tyrosine kinase 7 (DOK7) congenital myasthenic syndrome, which is one of the most common subtypes of this syndrome.
Tassone discusses the inclusion of fragile X syndrome in newborn screening.
Thank you for submitting a comment on this article. It will be reviewed by JAMA Neurology editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.